This site is intended for health professionals only!

Published on 1 January 2007

Share this story:
Twitter
LinkedIn
RELATED ARTICLES
Two-year data from clinical trial of HUMIRA®
Sanofi-aventis to acquire Genzyme for $74.00 in Cash per share
Takeover leads to deal shake-up
Antioxidant treats womb-cell condition
NICE approves nilotinib for chronic myeloid leukaemia

Once-daily combination therapies in HIV patients

teaser

Esteban Ribera
MD PhD
Head of HIV Infection
Infectious Diseases Division
Hospital Universitario Vall d’Hebr



Most read

1
Feedback: Automation systems in your hospital
2
Helapet introduce new, improved 20mm Vented Vial Adapter
3
User-friendly osteoporosis therapy launched
4
Merck agrees huge Vioxx settlement
5
Janssen-Cilag’s Stelara approved by NICE



Latest Issue

Read the latest issue >
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:
Twitter
LinkedIn
RELATED ARTICLES
Latest Xarelto® (Rivaroxaban) data to be presented at ESC
UK readies drug response to pig bug
JCVI not to recommend Bexsero®
Alzheimer’s antibody “milestone”
Using new technologies in hospital pharmacies